$0.00050
Tieni traccia delle ultime attività di insider trading Evelo Biosciences. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Evelo Biosciences.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Nov 08, 2023 | CSO, PRESIDENT R&D | 3.46K | $0.33 | -$1.04K | SELL-OPTIONS | 15.55% | 25.73K | Nov 07 - Nov 08 | ||
Nov 08, 2023 | CHIEF MEDICAL OFFICER | 3.40K | $0.33 | -$1.02K | SELL-OPTIONS | 25.00% | 16.98K | Nov 07 - Nov 08 | ||
Nov 08, 2023 | PRESIDENT & CEO | 1.00K | $0.33 | -$56.76 | SELL-OPTIONS | 5.97% | 17.76K | Nov 07 - Nov 08 | ||
Nov 08, 2023 | CHIEF FINANCIAL OFFICER | 4.69K | $0.33 | -$597.63 | SELL-OPTIONS | 26.69% | 22.26K | Nov 07 - Nov 08 | ||
Nov 03, 2023 | CSO, PRESIDENT R&D | 5.65K | $0.33 | -$2.26K | SELL-OPTIONS | 33.96% | 22.27K | Nov 01 - Nov 02 | ||
Nov 03, 2023 | CHIEF MEDICAL OFFICER | 5.65K | $0.33 | -$2.26K | SELL-OPTIONS | 71.10% | 13.59K | Nov 01 - Nov 02 | ||
Nov 03, 2023 | CHIEF FINANCIAL OFFICER | 8.50K | $0.33 | -$1.32K | SELL-OPTIONS | 93.74% | 17.57K | Nov 01 - Nov 02 | ||
Sep 29, 2023 | PRESIDENT & CEO | 13.00K | $3.94 | -$7.86K | SELL-OPTIONS | 346.40% | 16.76K | Sep 27 - Sep 28 | ||
Aug 09, 2023 | CSO, PRESIDENT R&D | 3.50K | $9.51 | -$29.75K | SELL-OPTIONS | 26.64% | 16.62K | Aug 07 - Aug 08 | ||
Aug 09, 2023 | PRESIDENT & CEO | 829.00 | $9.51 | -$3.25K | SELL-OPTIONS | 28.34% | 3.75K | Aug 07 - Aug 08 | ||
Aug 09, 2023 | CHIEF MEDICAL OFFICER | 3.07K | $9.51 | -$32.66K | SELL-OPTIONS | 62.89% | 7.94K | Aug 07 - Aug 08 | ||
Aug 09, 2023 | CHIEF FINANCIAL OFFICER | 4.50K | $9.51 | -$19.06K | SELL-OPTIONS | 98.32% | 9.07K | Aug 07 - Aug 08 | ||
Jul 13, 2023 | — | 5.41M | $2.31 | $12.50M | BUY | ∞ | 4.11M | Jul 11 | ||
Jun 12, 2023 | CSO, PRESIDENT R&D | -22.57K | $0.14 | -$3.20K | SELL | -7.92% | 262.56K | May 23 | ||
May 10, 2023 | CHIEF MEDICAL OFFICER | -66.73K | $0.13 | -$8.37K | SELL | -40.63% | 97.52K | May 08 | ||
May 10, 2023 | CSO, PRESIDENT R&D | -68.01K | $0.13 | -$8.54K | SELL | -19.26% | 285.13K | May 08 | ||
May 10, 2023 | CHIEF FINANCIAL OFFICER | -38.53K | $0.13 | -$4.84K | SELL | -29.64% | 91.47K | May 08 | ||
May 10, 2023 | PRESIDENT & CEO | -3.54K | $0.13 | -$443.89 | SELL | -5.70% | 58.51K | May 08 | ||
Jan 23, 2023 | PRINCIPAL ACCOUNTING OFFICER | 203.00 | $1.06 | -$160.12 | SELL-OPTIONS | ∞ | 203.00 | Jan 19 - Jan 23 | ||
Jun 01, 2022 | Flagship Ventures Fund IV General Partner LLCFlagship Ventures Fund IV LPFlagship Ventures Fund IVRx LPFlagship Ventures Opportunities Fund I General Partner LLCFlagship Ventures Opportunities Fund I LPNutritional Health LTP Fund General Partner LLCNutritional Health LTP Fund LPFlagship Pioneering IncNOUBAR AFEYAN | 10% OWNER | 27.40M | $1.46 | $40.00M | BUY | ∞ | 17.30M | May 27 | |
May 31, 2022 | CHIEF MEDICAL OFFICER | 34.25K | $1.46 | $50.00K | BUY | ∞ | 34.25K | May 27 | ||
May 31, 2022 | DIRECTOR | 342.46K | $1.46 | $500.00K | BUY | ∞ | 342.46K | May 27 | ||
May 31, 2022 | DIRECTOR | 17.12K | $1.46 | $25.00K | BUY | 25.57% | 84.08K | May 27 | ||
Feb 04, 2021 | 10% OWNER | 130.00K | $15.00 | $1.95M | BUY | 1.71% | 7.72M | Feb 02 | ||
Dec 14, 2020 | — | 7.70K | $6.66 | $51.26K | PURCHASE | 77.00% | 17.70K | Dec 11 | ||
Dec 02, 2020 | — | -3.00K | $5.17 | -$15.51K | SELL | -100.00% | 0.00 | Dec 01 |
Sfoglia insider trading su tutte le azioni.